Urine profile linked to future cancer risk in healthy adults
Five-year cancer risk ranged from 0.18% in the lowest urine-score group to 32% in the highest.Five-year cancer risk ranged from 0.18% in the lowest urine-score group to 32% in the highest.

171 papers19 new in 30 days
Five-year cancer risk ranged from 0.18% in the lowest urine-score group to 32% in the highest.Five-year cancer risk ranged from 0.18% in the lowest urine-score group to 32% in the highest.


People classified as high risk from retinal measurements had nearly threefold higher cancer risk over 12 years than those classified as low risk.People classified as high risk from retinal measurements had nearly threefold higher cancer risk over 12 years than those classified as low risk.

Ten-year cancer incidence was 1.84% at normal weight, 2.24% with class I obesity and 2.62% with class II obesity.Ten-year cancer incidence was 1.84% at normal weight, 2.24% with class I obesity and 2.62% with class II obesity.

Children with intellectual disability had a standardized cancer incidence ratio of 4.55 compared with an age- and sex-matched reference group in Denmark.Children with intellectual disability had a standardized cancer incidence ratio of 4.55 compared with an age- and sex-matched reference group in Denmark.

Compared with blood sugar marker levels of 5.0–6.9%, levels below 5.0% had an adjusted cancer hazard ratio of 1.28, a measure of relative risk.Compared with blood sugar marker levels of 5.0–6.9%, levels below 5.0% had an adjusted cancer hazard ratio of 1.28, a measure of relative risk.




Over 11 years, oral cancer developed in 4.13% of people positive on both screens versus 0.13% of those negative on both.Over 11 years, oral cancer developed in 4.13% of people positive on both screens versus 0.13% of those negative on both.

In 33,258 newly diagnosed adults and 16,807 five-year survivors, non-cancer multimorbidity affected 60% to 86% at diagnosis and 70% to 90% in survivorship.In 33,258 newly diagnosed adults and 16,807 five-year survivors, non-cancer multimorbidity affected 60% to 86% at diagnosis and 70% to 90% in survivorship.

In a study of 9,828 participants, researchers identified 1,732 plasma protein associations across 25 cancers, with 49% statistically replicated in an independent cohort.In a study of 9,828 participants, researchers identified 1,732 plasma protein associations across 25 cancers, with 49% statistically replicated in an independent cohort.


Participants in the highest quartile of allostatic load had over double the cancer risk compared to the lowest quartile, showing an odds ratio of 2.24.Participants in the highest quartile of allostatic load had over double the cancer risk compared to the lowest quartile, showing an odds ratio of 2.24.


Colon cancer rates rose an estimated 2.7% annually at ages 20–49 versus 0.4% at ages 50–84; kidney cancer rates rose 2.7% versus 1.2%.Colon cancer rates rose an estimated 2.7% annually at ages 20–49 versus 0.4% at ages 50–84; kidney cancer rates rose 2.7% versus 1.2%.



